184 related articles for article (PubMed ID: 28512370)
21. A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency caesarean section.
Tripathi A; Somwanshi M; Singh B; Bajaj P
Can J Anaesth; 1995 Sep; 42(9):797-800. PubMed ID: 7497561
[TBL] [Abstract][Full Text] [Related]
22. Contact dermatitis caused by intermediate products in the manufacture of clenbuterol, ranitidine base, and ranitidine hydrochloride.
Romaguera C; Grimalt F; Vilaplana J
Dermatol Clin; 1990 Jan; 8(1):115-7. PubMed ID: 2137389
[TBL] [Abstract][Full Text] [Related]
23. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
[TBL] [Abstract][Full Text] [Related]
24. Late hypersensitivity to omeprazole and other proton pump inhibitors.
Pirson F; Geubel A; Marot L
Acta Clin Belg; 2012; 67(4):301-3. PubMed ID: 23019809
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
26. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
[TBL] [Abstract][Full Text] [Related]
27. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
Kager L; Lindberg G; Nilsson LH; Seensalu R; Backman L; Granström L; Kollberg B; Sidenvall L; Moberg S; Sörstad J
Hepatogastroenterology; 1991 Aug; 38(4):287-90. PubMed ID: 1937372
[TBL] [Abstract][Full Text] [Related]
28. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
29. H2-blocker modulates heart rate variability.
Ooie T; Saikawa T; Hara M; Ono H; Seike M; Sakata T
Heart Vessels; 1999; 14(3):137-42. PubMed ID: 10776806
[TBL] [Abstract][Full Text] [Related]
30. Hypomagnesaemia and hypocalcaemia in a patient with systemic sclerosis: role of proton pump inhibitors.
Perez MO; Neves EF; Bortolai CB; Sampaio-Barros PD; Andrade DC; Seguro LP
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-225-7. PubMed ID: 25068521
[TBL] [Abstract][Full Text] [Related]
31. Allergic contact dermatitis caused by ranitidine hydrochloride in a veterinary product.
Meani R; Nixon R
Contact Dermatitis; 2015 Aug; 73(2):125-6. PubMed ID: 25891273
[No Abstract] [Full Text] [Related]
32. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
34. Occupational allergic contact dermatitis caused by omeprazole in a horse breeder.
Al-Falah K; Schachter J; Sasseville D
Contact Dermatitis; 2014 Dec; 71(6):377-8. PubMed ID: 25377305
[No Abstract] [Full Text] [Related]
35. Severe ranitidine-induced anaphylaxis: a case report and literature review.
Aouam K; Bouida W; Ben Fredj N; Chaabane A; Boubaker H; Boukef R; Boughattas NA; Nouira S
J Clin Pharm Ther; 2012 Aug; 37(4):494-6. PubMed ID: 22059646
[TBL] [Abstract][Full Text] [Related]
36. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
37. Prescription changes in patients with gastrointestinal disorders after withdrawal of ranitidine: a nationwide population-based cohort study.
Ku M; Je NK
Curr Med Res Opin; 2023 Feb; 39(2):197-203. PubMed ID: 36519289
[TBL] [Abstract][Full Text] [Related]
38. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
39. Rhinitis and asthma due to ranitidine.
Martínez AJ; Callejo Melgosa A; Fuentes GM; Martín García C
J Investig Allergol Clin Immunol; 2006; 16(2):142-3. PubMed ID: 16689191
[TBL] [Abstract][Full Text] [Related]
40. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.
Lobera T; Navarro B; Del Pozo MD; González I; Blasco A; Escudero R; Venturini M; Alarcón E
J Investig Allergol Clin Immunol; 2009; 19(1):57-60. PubMed ID: 19274931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
